#canyon-partners

#canyon-partners

I founded this company to impact and improve lives, and that mission has never burned brighter, Brian Buffini said in a statement. As chairman, I'm free to do what I do best, create world-class content, lead from the stage, and champion Working by Referral.

Awards may be encouraging and occasionally useful for visibility, but they are weak indicators of validation and poor predictors of long-term success. In the longevity and healthspan industry, where timelines are long and claims are easy to overstate, venture capital ultimately follows alignment and evidence, not applause received at glitzy industry events.

I don't take founders here for exercise. I take them here because the controlled environment of a boardroom practically demands rehearsed answers. The trail does not. I don't prepare a script for these walks. In fact, that's the point. The pitch is already done; I know the metrics. Now I want to know the human.

Felser noticed it was a common occurrence among startups producing novel materials. Fesler, who previously founded and invested in software startups, said the problem they faced seemed a bit unfair. "Software companies sell at a negative margin all the time in the beginning, you know, Uber, Lyft, you can look at lots of different examples," he said. "But for materials companies, they they're not allowed to do that. One of the questions I had is, 'why is that?'"

Raising venture capital too early can cost you control, leverage and even your company. Early capital is often highly dilutive, selling off your future before your blueprint is complete. The difference between lighting a spark and burning your equity to ash is a lesson many founders learn too late.